BioXcel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.About BTAI
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions.
CEOVimal D. Mehta
CEOVimal D. Mehta
Employees37
Employees37
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2017
Founded2017
Employees37
Employees37
BTAI Key Statistics
Market cap43.85M
Market cap43.85M
Price-Earnings ratio-0.21
Price-Earnings ratio-0.21
Dividend yield—
Dividend yield—
Average volume715.52K
Average volume715.52K
High today$2.04
High today$2.04
Low today$1.92
Low today$1.92
Open price$2.00
Open price$2.00
Volume506.75K
Volume506.75K
52 Week high$8.08
52 Week high$8.08
52 Week low$1.17
52 Week low$1.17
Stock Snapshot
The current BioXcel Therapeutics(BTAI) stock price is $2.01, with a market capitalization of 43.85M. The stock trades at a price-to-earnings (P/E) ratio of -0.21.
On 2026-01-10, BioXcel Therapeutics(BTAI) stock moved within a range of $1.92 to $2.04. With shares now at $2.01, the stock is trading +4.7% above its intraday low and -1.5% below the session's peak.
Trading volume for BioXcel Therapeutics(BTAI) stock has reached 506.75K, versus its average volume of 715.52K.
Over the past 52 weeks, BioXcel Therapeutics(BTAI) stock has traded between a high of $8.08 and a low of $1.17.
Over the past 52 weeks, BioXcel Therapeutics(BTAI) stock has traded between a high of $8.08 and a low of $1.17.
People also own
Based on the portfolios of people who own BTAI. This list is generated using Robinhood data, and it’s not a recommendation.